The mortality rate due to diabetes from 1989 through 1991 increased by 61 percent when compared to the 3 year period of 1999 through 2001.
Researchers at the Albert Einstein College of Medicine of Yeshiva University have documented a dramatic upsurge in diabetes-related deaths and illnesses in New York City, including a sharp increase in diabetic patients hospitalized with heart attacks. They warn that this upsurge in diabetic complications may end the long-term trend of progressively fewer heart attacks and heart-attack deaths in the U.S.
"Diabetes has reached epidemic proportions in the U.S., and the leading cause of death among people with diabetes is coronary heart disease," notes Dr. Michael Alderman, professor of epidemiology and population health at Albert Einstein College of Medicine and senior author of the paper. We expected to see an increase in hospitalizations due to heart attacks among diabetics, but we were surprised by the magnitude of the increase and the sharply rising trend indicated by these findings.
The Einstein researchers looked at New York City Department of Health mortality records for two three-year periods–1989 through 1991 and 1999 through 2001. This information included the underlying cause of death listed on each individual’s death certificate.
During the decade between these two three-year time spans, mortality rates due to stroke, cancer and all other diseases declined–with the notable exception of diabetes. The mortality rate due to diabetes over that period increased by 61 percent.
As for hospitalizations over this time, the percentage of all heart attacks among people with diabetes increased from 21 percent to 36 percent–with the total number of diabetics suffering heart attacks more than doubling, from 2,951 to 6,048. The result: The total number of heart attacks in New York City failed to decline from 1989-1991 to 1999-2001 and instead stayed the same. And while days spent in hospital due to heart attack fell overall in New York City, for diabetics they increased by a striking 51 percent.
"Over the past 30 years, the U.S. has achieved dramatic reductions in illnesses and deaths from coronary heart disease," says Dr. Jing Fang, the study’s lead author. "But if this upsurge in diabetes-associated deaths and illnesses continues, it may put an end to the progress we’ve made in combating illness and death from coronary heart disease."
Diabetes Feb. 2006
================================
DID YOU KNOW:
Clinical trials demonstrate that Beta Fast GXR Glucose Balance reduces blood
glucose and HbA1c levels up to 28%. Analytically tested for quality and produced in a cGMP/NNFA/FDA approved facility, Beta Fast GXR Glucose Balance, extended release Gymnema sylvestre extract provides a simple, safe, effective method to promote healthy glucose metabolism. Just two tablets per day help your patients maintain a natural glucose balance. Trial results and special pricing at https://www.betafast.com
Advertisement
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.